Alnylam Pharmaceuticals, Inc.

0HD2•London Stock Exchange

United Kingdom

Need professional-grade analysis? Visit stockanalysis.com

£307.15

-3.58%

End of day

Market Cap

N/A

P/E Ratio

N/A

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio	1W	1M	3M	6M	1Y	5Y	Score
Sortino	—	-2.29	-1.90	-1.66	0.34	—	-1.09
Calmar	—	-5.77	-2.22	-1.34	0.24	—	-1.60
Sharpe	—	-1.74	-1.52	-1.34	0.23	—	-0.87
Omega	—	0.67	0.65	0.74	1.08	—	0.83
Martin	—	-10.38	-3.18	-2.29	0.55	—	-2.62
Ulcer	—	3.44	18.55	22.02	16.49	—	16.65

Also Listed On

ALNY.US

United States · USD

$41.57B

Alnylam Pharmaceuticals, Inc. (0HD2) Price Performance

Alnylam Pharmaceuticals, Inc. (0HD2) trades on London Stock Exchange in GBP. The stock currently trades at GBP307.15, down 3.58% from the previous close.

Over the past year, 0HD2 has traded between a low of GBP221.00 and a high of GBP495.20. The stock has gained 12.0% over this period. It is currently 38.0% below its 52-week high.

Company Info

Sector: N/A
Industry: N/A
Exchange: London Stock Exchange
Currency: GBP
Country: United Kingdom

Financial Metrics

Revenue (TTM): N/A
EBITDA: N/A
Profit Margin: N/A
EPS (TTM): N/A
Book Value: N/A

Technical Indicators

52 Week High: £500.21
52 Week Low: £209.75
50 Day MA: £339.60
200 Day MA: £391.06
Beta: N/A

Valuation

Trailing P/E: N/A
Forward P/E: N/A
Price/Sales: N/A
Price/Book: N/A
Enterprise Value: N/A